Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 3/2022

02-09-2021 | Pathology | ENT • Review

Nasal function and CPAP use in patients with obstructive sleep apnoea: a systematic review

Authors: Marina Brimioulle, Konstantinos Chaidas

Published in: Sleep and Breathing | Issue 3/2022

Login to get access

Abstract

Purpose

This systematic review was conducted to answer the following 3 questions: ‘Does nasal pathology affect CPAP use?’, ‘What is the effect of CPAP on the nose?’ and ‘Does treatment of nasal pathology affect CPAP use?’.

Methods

Pubmed and Scopus databases were searched for articles relevant to the study questions up to October 2020.

Results

Sixty-three articles were selected, of which a majority were observational studies. Most studies identified a correlation between larger nasal cross-sectional area or lower nasal resistance and higher CPAP compliance or lower CPAP pressures; however, nasal symptoms at baseline did not appear to affect CPAP use. The effect of CPAP on the nose remains uncertain: while most studies suggested increased mucosal inflammation with CPAP, those investigating symptoms presented contradictory results, with some reporting an increase and others an improvement in nasal symptoms. Evidence is clearer for nasal surgery leading to an increase in CPAP compliance and a decrease in CPAP pressures, whereas there is little evidence available for the use of topical nasal steroids.

Conclusion

There appears to be a link between nasal volumes or nasal resistance and CPAP compliance, an increase in nasal inflammation caused by CPAP and a beneficial effect of nasal surgery on CPAP usage, but no significant effect of CPAP on nasal patency or effect of topical steroids on CPAP compliance. Results are more mitigated with regard to the effect of nasal symptoms on CPAP use and vice versa, and further research in this area would help identify patients who may benefit from additional support or treatment alongside CPAP.
Literature
1.
American Academy of Sleep Medicine (2001) The international classification of sleep disorders, revised: diagnostic and coding manual. Illinois, Chicago
2.
Senaratna C et al (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81
3.
Marshall N et al (2008) Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 31(8):1079–85PubMedPubMedCentral
4.
Young T et al (1997) Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 20(8):608–13PubMedCrossRef
5.
Sateia M (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146(5):1387–1394PubMedCrossRef
6.
Sullivan C et al (1981) Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1(8225):862–5PubMedCrossRef
7.
American Thoracic Society (1994) Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Am J Respir Crit Care Med 150:1738–1745
8.
Giles T et al (2006) Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 25(1):CD001106
9.
Weaver T, Sawyer A (2010) Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions. Indian J Med Res 131:245–58PubMed
10.
Kohler M et al (2010) Predictors of long-term compliance with continuous positive airway pressure. Thorax 65(9):829–32PubMedCrossRef
11.
Randerath W et al (2002) Efficiency of cold passover and heated humidification under continuous positive airway pressure. Eur Respir J 20(1):183–6PubMedCrossRef
12.
Massie C et al (1999) Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 116(2):403–8PubMedCrossRef
13.
Mador M et al (2005) Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest 128(4):2151–8PubMedCrossRef
14.
Hollandt J, Mahlerwein M (2003) Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA). Sleep & breathing  7(2):87–94CrossRef
15.
16.
Catcheside P (2010) Predictors of continuous positive airway pressure adherence.  Med Rep 2:70
17.
Kalan A et al (1999) Adverse effects of nasal continuous positive airway pressure therapy in sleep apnoea syndrome. J Laryngol Otol 113(10):888–92PubMedCrossRef
18.
Georgalas C (2011) The role of the nose in snoring and obstructive sleep apnoea: an update. Eur Arch Otorhinolaryngol 268(9):1365–1373
19.
Masdeu M et al (2011) Awake measures of nasal resistance and upper airway resistance on CPAP during sleep. J Clin Sleep Med: JCSM: official publication of the American Academy of Sleep Medicine 7(1):31–40
20.
Li H et al (2005) Acoustic reflection for nasal airway measurement in patients with obstructive sleep apnea-hypopnea syndrome. Sleep 28(12):1554–9PubMedCrossRef
21.
Mo S et al (2021) Nasal peak inspiratory flow in healthy and obstructed patients: systematic review and meta-analysis. Laryngoscope 131(2):260–267PubMedCrossRef
22.
Desfonds P et al (1998) Nasal resistance in snorers with or without sleep apnea: effect of posture and nasal ventilation with continuous positive airway pressure. Sleep 21(6):625–32PubMedCrossRef
23.
Stewart M et al (2004) Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol Head Neck Surg 130(2):157–163PubMedCrossRef
24.
Juniper E et al (1999) Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 104(2 Pt 1):364–9PubMedCrossRef
25.
Rhee J et al (2014) A systematic review of patient-reported nasal obstruction scores: defining normative and symptomatic ranges in surgical patients. JAMA Facial Plast Surg 16(3):219–25PubMedPubMedCentralCrossRef
26.
Howarth P et al (2005) Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol 115(3 Suppl 1):S414-41PubMedCrossRef
27.
Morris L et al (2006) Acoustic rhinometry predicts tolerance of nasal continuous positive airway pressure: a pilot study. Am J Rhinol 20(2):133–7PubMedCrossRef
28.
29.
Värendh M et al (2019) PAP treatment in patients with OSA does not induce long-term nasal obstruction. J Sleep Res 28(5):e12768PubMedCrossRef
30.
So Y et al (2009) Initial adherence to autotitrating positive airway pressure therapy: influence of upper airway narrowing. Clin Exp Otorhinolaryngol 2(4):181–5PubMedPubMedCentralCrossRef
31.
Haddad F et al (2013) The influence of nasal abnormalities in adherence to continuous positive airway pressure device therapy in obstructive sleep apnea patients. Sleep Breath 17(4):1201–7PubMedCrossRef
32.
Kim H et al (2007) Influence of upper airway narrowing on the effective continuous positive airway pressure level. Laryngoscope 117(1):82–5PubMedCrossRef
33.
Camacho M et al (2016) Inferior turbinate size and CPAP titration based treatment pressures: no association found among patients who have not had nasal surgery. Int J Otolaryngol, Epub 2016
34.
Wakayama T, Suzuki M, Tanuma T (2016) Effect of nasal obstruction on continuous positive airway pressure treatment: computational fluid dynamics analyses. PloS One 11(3):e0150951PubMedPubMedCentralCrossRef
35.
Sugiura T et al (2007) Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome. Respiration 74(1):56–60PubMedCrossRef
36.
37.
38.
Hueto J et al (2016) Usefulness of rhinomanometry in the identification and treatment of patients with obstructive sleep apnoea: an algorithm for predicting the relationship between nasal resistance and continuous positive airway pressure. a retrospective study. Clin Otolaryngol 41(6):750–757PubMedCrossRef
39.
Parikh N et al (2014) Clinical control in the dual diagnosis of obstructive sleep apnea syndrome and rhinitis: a prospective analysis. Am J Rhinol allergy 28(1):e52-5PubMedCrossRef
40.
Kreivi H et al (2010) Frequency of upper airway symptoms before and during continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome. Respiration 80(6):488–94PubMedCrossRef
41.
Shadan F et al (2005) Nasal cytology: a marker of clinically silent inflammation in patients with obstructive sleep apnea and a predictor of noncompliance with nasal CPAP therapy. J Clin Sleep Med 1(3):266–270PubMedCrossRef
42.
Hoffstein V et al (1992) Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 145(4 Pt 1):841–845PubMedCrossRef
43.
Pépin J et al (1995) Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 107(2):375–81PubMedCrossRef
44.
Meslier N et al (1998) A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 12(1):185–92PubMedCrossRef
45.
Lam A et al (2017) Validated measures of insomnia, function, sleepiness, and nasal obstruction in a CPAP alternatives clinic population. J Clin Sleep Med  13(8):949–957PubMedPubMedCentralCrossRef
46.
Baltzan M, Elkholi O, Wolkove N (2009) Evidence of interrelated side effects with reduced compliance in patients treated with nasal continuous positive airway pressure. Sleep Med 10(2):198–205PubMedCrossRef
47.
Duong M et al (2005) Use of heated humidification during nasal CPAP titration in obstructive sleep apnoea syndrome. Eur Respir J 26(4):679–85PubMedCrossRef
48.
Koutsourelakis I et al (2011) Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification. Eur Respir J 37(3):587–94PubMedCrossRef
49.
Yu C et al (2013) The effects of heated humidifier in continuous positive airway pressure titration. Sleep Breath 17(1):133–138PubMedCrossRef
50.
Lojander J, Brander P, Ammälä K (1999) Nasopharyngeal symptoms and nasal continuous positive airway pressure therapy in obstructive sleep apnoea syndrome. Acta Otolaryngol 119(4):497–502PubMedCrossRef
51.
Pitts K et al (2018) The effect of continuous positive airway pressure therapy on nasal patency. Int Forum Allergy Rhinol 8(10):1136–1144PubMedCrossRef
52.
Cisternas A et al (2017) Effects of CPAP in patients with obstructive apnoea: is the presence of allergic rhinitis relevant? Sleep Breath  21(4):893–900PubMedCrossRef
53.
Skirko J et al (2020) Association of allergic rhinitis with change in nasal congestion in new continuous positive airway pressure users. JAMA Otolaryngol Head Neck Surg 146(6):523–529PubMedCrossRef
54.
Rakotonanahary D et al (2001) Predictive factors for the need for additional humidification during nasal continuous positive airway pressure therapy. Chest 119(2):460–5PubMedCrossRef
55.
Ruhle K et al (2011) Quality of life, compliance, sleep and nasopharyngeal side effects during CPAP therapy with and without controlled heated humidification. Sleep Breath 15(3):479–485PubMedCrossRef
56.
Brander P, Soirinsuo M, Lohela P (1999) Nasopharyngeal symptoms in patients with obstructive sleep apnea syndrome Effect of nasal CPAP treatment. Respiration 66(2):128–135PubMedCrossRef
57.
Yang Q et al (2018) Effect of continuous positive airway pressure on allergic rhinitis in patients with obstructive sleep apnea-hypopnea syndrome. Ther Clin Risk Manag 14:1507–1513PubMedPubMedCentralCrossRef
58.
Balsalobre L et al (2017) Acute impact of continuous positive airway pressure on nasal patency. Int Forum Allergy Rhinol 7(7):712–717PubMedCrossRef
59.
İriz A et al (2017) Does nasal congestion have a role in decreased resistance to regular CPAP usage? Eur Arch Otorhinolaryngol 274(11):4031–4034PubMedCrossRef
60.
Alahmari M et al (2012) Dose response of continuous positive airway pressure on nasal symptoms, obstruction and inflammation in vivo and in vitro. Eur Respir J 40(5):1180–90PubMedCrossRef
61.
Skoczyński S et al (2008) Short-term CPAP treatment induces a mild increase in inflammatory cells in patients with sleep apnoea syndrome. Rhinology 46(2):144–50PubMed
62.
Bossi R et al (2004) Effects of long-term nasal continuous positive airway pressure therapy on morphology, function, and mucociliary clearance of nasal epithelium in patients with obstructive sleep apnea syndrome. Laryngoscope 114(8):1431–4PubMedCrossRef
63.
Lacedonia D et al (2011) Effect of CPAP-therapy on bronchial and nasal inflammation in patients affected by obstructive sleep apnea syndrome. Rhinology 49(2):232–7PubMedCrossRef
64.
Gelardi M et al (2012) Regular CPAP utilization reduces nasal inflammation assessed by nasal cytology in obstructive sleep apnea syndrome. Sleep Med 13(7):859–63PubMedCrossRef
65.
Constantinidis J et al (2000) Fine-structural investigations of the effect of nCPAP-mask application on the nasal mucosa. Acta Otolaryngol 120(3):432–7PubMedCrossRef
66.
67.
Vilaseca I et al (2016) Early effects of continuous positive airway pressure in a rodent model of allergic rhinitis. Sleep Med 27–28:25–27PubMedCrossRef
68.
Sommer J et al (2014) Functional short- and long-term effects of nasal CPAP with and without humidification on the ciliary function of the nasal respiratory epithelium. Sleep Breath 18(1):85–93PubMedCrossRef
69.
White D, Nates R, Bartley J (2017) Model identifies causes of nasal drying during pressurised breathing. Respir Physiol Neurobiol 243:97–100PubMedCrossRef
70.
Fischer Y et al (2008) Effects of nasal mask leak and heated humidification on nasal mucosa in the therapy with nasal continuous positive airway pressure (nCPAP). Sleep Breath 12(4):353–357PubMedCrossRef
71.
Camacho M et al (2015) The effect of nasal surgery on continuous positive airway pressure device use and therapeutic treatment pressures: a systematic review and meta-analysis. Sleep 38(2):279–86PubMedPubMedCentralCrossRef
72.
Powell N et al (2001) Radiofrequency treatment of turbinate hypertrophy in subjects using continuous positive airway pressure: a randomized, double-blind, placebo-controlled clinical pilot trial. Laryngoscope 111(10):1783–90PubMedCrossRef
73.
Friedman M et al (2000) Effect of improved nasal breathing on obstructive sleep apnea. Otolaryngol Head Neck Surg 122(1):71–74PubMedCrossRef
74.
Sufioğlu M et al (2012) The efficacy of nasal surgery in obstructive sleep apnea syndrome: a prospective clinical study. Eur Arch Otorhinolaryngol 269(2):487–494PubMedCrossRef
75.
Nakata S et al (2005) Nasal resistance for determinant factor of nasal surgery in CPAP failure patients with obstructive sleep apnea syndrome. Rhinology 43(4):296–9PubMed
76.
Poirier J, George C, Rotenberg B (2014) The effect of nasal surgery on nasal continuous positive airway pressure compliance. Laryngoscope 124(1):317–9PubMedCrossRef
77.
Zonato A et al (2006) Upper airway surgery: the effect on nasal continuous positive airway pressure titration on obstructive sleep apnea patients. Eur Arch Otorhinolaryngol 263(5):481–486PubMedCrossRef
78.
Sériès F, St Pierre S, Carrier G (1992) Effects of surgical correction of nasal obstruction in the treatment of obstructive sleep apnea. Am Rev Respir Dis 146(5 Pt 1):1261–5PubMedCrossRef
79.
Bican A et al (2010) What is the efficacy of nasal surgery in patients with obstructive sleep apnea syndrome? J Craniofac Surg 21(6):1801–6PubMedCrossRef
80.
Iwata N et al (2020) Clinical indication of nasal surgery for the CPAP intolerance in obstructive sleep apnea with nasal obstruction. Auris Nasus Larynx 47(6):1018–1022PubMedCrossRef
81.
Means C, Camacho M, Capasso R (2016) Long-term outcomes of radiofrequency ablation of the inferior turbinates. Indian J Otolaryngol Head Neck Surg 68(4):424–428PubMedCrossRef
82.
83.
Kempfle J et al (2017) A cost-effectiveness analysis of nasal surgery to increase continuous positive airway pressure adherence in sleep apnea patients with nasal obstruction. Laryngoscope 127(4):977–983PubMedCrossRef
84.
Ryan S et al (2009) Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure. J Clin Sleep Med 5(5):422–427PubMedPubMedCentralCrossRef
85.
Strobel W et al (2011) Topical nasal steroid treatment does not improve CPAP compliance in unselected patients with OSAS. Respir Med 105(2):310–5PubMedCrossRef
86.
Charakorn N et al (2017) The effects of topical nasal steroids on continuous positive airway pressure compliance in patients with obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath 21(1):3–8PubMedCrossRef
87.
Gelardi M et al (2019) Internal nasal dilator in patients with obstructive sleep apnea syndrome and treated with continuous positive airway pressure. Acta bio-medica : Atenei Parmensis 90(2-S):24–27
88.
Collen J et al (2009) Clinical and polysomnographic predictors of short-term continuous positive airway pressure compliance. Chest 135(3):704–709PubMedCrossRef
89.
Kennedy B et al (2019) Pressure modification or humidification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev 12(12):CD003531PubMed
90.
Tárrega J et al (2003) Nasal resistance and continuous positive airway pressure treatment for sleep apnea/hypopnea syndrome. Arch Bronconeumol 39(3):106–10PubMedCrossRef
Metadata
Title
Nasal function and CPAP use in patients with obstructive sleep apnoea: a systematic review
Authors
Marina Brimioulle
Konstantinos Chaidas
Publication date
02-09-2021
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 3/2022
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-021-02478-x

Other articles of this Issue 3/2022

Sleep and Breathing 3/2022 Go to the issue

Sleep Breathing Physiology and Disorders • Original Article

Periodic breathing in patients with stable obstructive sleep apnea on long-term continuous positive airway pressure treatment: a retrospective study using CPAP remote monitoring data

Sleep Breathing Physiology and Disorders • Original Article

The predictive value of drug-induced sleep endoscopy for treatment success with a mandibular advancement device or positional therapy for patients with obstructive sleep apnea

Hypoxia • Original Article

Association between nocturnal hypoxemic burden and glucose metabolism

Sleep Breathing Physiology and Disorders • Original Article

Circulating levels of ghrelin, galanin, and orexin-A orexigenic neuropeptides in obstructive sleep apnea syndrome

Neurology • Original Article

The relationship between sleep disorders, anxiety, depression, and cognitive function with restless legs syndrome (RLS) in the elderly

Basic Science • Original Article

Densely granulated adenoma pattern is associated with an increased risk of obstructive sleep apnea in patients with acromegaly
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits